Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kluth

Showing results (751-760 of 1,145) with videos related to

Pageof 115
Sort By:
Cancers|December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor OutcomesHenning Plage, Nadine Biernath, Kira Furlano, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Pathology, Research and Practice|October 30, 2021
DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samplesKristina Jansen, Nagina Farahi, Franziska Büscheck, et al.
Pathology Oncology Research : POR|July 14, 2021
Napsin A Expression in Human Tumors and Normal TissuesSören Weidemann, Jan Lukas Böhle, Hendrina Contreras, et al.
Pathology, Research and Practice|March 7, 2024
Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumorsFrank Jacobsen, Ramesh Pushpadevan, Florian Viehweger, et al.
Clinical Genitourinary Cancer|June 21, 2023
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive NephrectomyCristina Cano Garcia, Rocco S Flammia, Mattia Piccinelli, et al.
Diagnostics (Basel, Switzerland)|July 15, 2026
MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor EntitiesViktor Reiswich, Henry Recksiek, Katharina Möller, et al.
Biomarker Research|January 26, 2021
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumorsStefan Steurer, Claudia Riemann, Franziska Büscheck, et al.
Technology in Cancer Research & Treatment|September 22, 2021
MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue SamplesSebastian Dwertmann Rico, Moritz Mahnken, Franziska Büscheck, et al.
Pageof 115

Showing results (751-760 of 1,145) with videos related to

Sort By:
Pageof 115
Cancers|December 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor OutcomesHenning Plage, Nadine Biernath, Kira Furlano, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
Human Pathology|September 24, 2022
GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladderHenning Plage, Henrik Samtleben, Sebastian Hofbauer, et al.
Pathology, Research and Practice|October 30, 2021
DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samplesKristina Jansen, Nagina Farahi, Franziska Büscheck, et al.
Pathology Oncology Research : POR|July 14, 2021
Napsin A Expression in Human Tumors and Normal TissuesSören Weidemann, Jan Lukas Böhle, Hendrina Contreras, et al.
Pathology, Research and Practice|March 7, 2024
Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumorsFrank Jacobsen, Ramesh Pushpadevan, Florian Viehweger, et al.
Clinical Genitourinary Cancer|June 21, 2023
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive NephrectomyCristina Cano Garcia, Rocco S Flammia, Mattia Piccinelli, et al.
Diagnostics (Basel, Switzerland)|July 15, 2026
MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor EntitiesViktor Reiswich, Henry Recksiek, Katharina Möller, et al.
Biomarker Research|January 26, 2021
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumorsStefan Steurer, Claudia Riemann, Franziska Büscheck, et al.
Technology in Cancer Research & Treatment|September 22, 2021
MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue SamplesSebastian Dwertmann Rico, Moritz Mahnken, Franziska Büscheck, et al.
Pageof 115